Lila Ramaiah

Johnson & Johnson (United States) — United States

Veterinary · Health Sciences

13h-index475citations63works2.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Animal testing and alternatives(19), Immunotoxicology and immune responses(19), Clinical Laboratory Practices and Quality Control(8), Biosimilars and Bioanalytical Methods(8), Erythrocyte Function and Pathophysiology(6)

Publications62 total

Toxicologic Pathology Forum*: Summary of the 2024 Society of Toxicologic Pathology Town Hall and 2025 STP Member Survey on Determining and Communicating Adversity
Toxicologic Pathology·2025
STP Town Hall Discussion on the Use of Virtual Control Groups in Nonclinical Toxicity Studies
Toxicologic Pathology·2025
#3745 Assay validation and quantification of new urinary kidney safety biomarker candidates for the detection of glomerular injury
Nephrology Dialysis Transplantation·2025
P06-22 Assay validation and quantification of novel urinary kidney safety biomarker candidates for the detection of glomerular injury in clinical specimens
Toxicology Letters·2025
Toxicologic Pathology Forum*: Opinion on Qualitative Severity Descriptors to Express Magnitude of Changes in Clinical Pathology Endpoints in Nonclinical Toxicity Studies
Toxicologic Pathology·2025
Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies
Toxicologic Pathology·2025
Scientific and Regulatory Policy Committee Points to Consider: Proposal and Recommendations to Reduce Euthanasia of Control Nonhuman Primates in Nonclinical Toxicity Studies
Toxicologic Pathology·2025
Hematopoietic System
Elsevier eBooks·2025
Contributors
Elsevier eBooks·2025
Session 4: mRNA and Self-Amplifying RNA (saRNA): Opportunities for Disease Prevention and Therapy.
UNC Libraries·2024Open Access
Session 4: mRNA and Self-Amplifying RNA (saRNA): Opportunities for Disease Prevention and Therapy
Toxicologic Pathology·2024Open Access
A cynomolgus monkey <i>E. coli</i> urinary tract infection model confirms efficacy of new FimH vaccine candidates
Infection and Immunity·2024· 9 citedOpen Access
Toxicological Assessments of a Pandemic COVID-19 Vaccine—Demonstrating the Suitability of a Platform Approach for mRNA Vaccines
UNC Libraries·2024Open Access
Anti-Drug Antibody Incidence Comparison of Therapeutic Proteins Administered Via Subcutaneous vs. Intravenous Route
The AAPS Journal·2024· 8 cited
Points to consider regarding the use and implementation of virtual controls in nonclinical general toxicology studies
Regulatory Toxicology and Pharmacology·2024· 15 cited
Considerations for the Identification and Conveyance of Clinical Pathology Findings in Preclinical Toxicity Studies: Results From the 9th ESTP International Expert Workshop
Toxicologic Pathology·2024· 1 cited
Translation of nonclinical to clinical safety findings for 27 biotherapeutics
Toxicology and Applied Pharmacology·2024· 6 citedOpen Access
Magnitude of Urine Albumin and KIM-1 Changes Can be Used to Differentiate Glomerular Injury From Tubular Injury in Rats
Toxicologic Pathology·2024· 2 citedOpen Access
The Hematopoietic System: Evaluation and Data Interpretation in Nonclinical Safety Studies
Elsevier eBooks·2024
Effects of 2,3‐DPG knockout on SCD phenotype in Townes SCD model mice
American Journal of Hematology·2023· 1 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Niraj Tripathi(8), Lindsay Tomlinson(6), Denise I. Bounous(6), Allison Vitsky(6), Laura Boone(5), Adam D. Aulbach(4), Laura C. Cregar(4), Daniela Ennulat(4), Cynthia M. Rohde(4), Rani S. Sellers(4), Tara Arndt(4), A. Eric Schultze(4), Florence Poitout‐Belissent(3), William J. Reagan(3), Adeyemi O. Adedeji(3), Holly L. Jordan(3), Susan A. Elmore(3), Warren E. Glaab(3), Nancy Everds(3), Yi‐Zhong Gu(3)